Publications – vacv

Latestpublications

VacV scientists have published numerous papers in peer-reviewed journals.

Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer

Publication : Journal for ImmunoTherapy of Cancer

Authors : Dr Renato Brito Baleeiro, Dr Peng Liu, Dr Louisa S Chard Dunmall, Dr Carmela Di Gioia, Dr Ai Nagano, Dr Lauren Cutmore , Dr Jun Wang, Prof. Claude Chelala, Dr Lydon Wainaina Nyambura, Prof. Peter Walden, Prof. Nicholas Lemoine and Prof. Yaohe Wang

Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus

Publication : Europe PMC

Authors : Ferguson M, Chard Dunmall LS, Gangeswaren R, Marelli G, Tysome J, Burns E, Whitehead MA, Aksoy E, Alusi G, Hiley C, Ahmed, J, Vanhaesebroeck B, Lemoine NR and Wang Y. (2020)

An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition

Publication : Molecular Therapy Oncolytics

Authors : Sun Y, Zhang Z, Zhang C, Zhang N, Chu Y, Chard Dunmall LS, Lemoine NR and Wang Y (2022)

Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy

Publication : Frontiers

Authors : Baleeiro RB, Chard Dunmall LS, Liu P, Lu S, Lone Y, Lemoine NR and Wang Y (2022).

MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy

Publication : Taylor & Francis Online

Authors : Baleeiro RB, Bouwens CJ, Liu P, Di Gioia C, Chard Dunmall LS, Nagano A, Gangeswaran R, Chelala C, Kocher HM, Lemoine NR and Wang Y (2022)

A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer

Publication : BMJ Journals

Authors : Marelli G, Chard Dunmall LS, Yuan M, Di Gioia C, Miao J, Cheng Z, Zhang Z, Liu P, Lemoine NR and Wang Y (2021).

Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers

Publication : Aging

Authors : Lan T, Xue X, Dunmall LC, Miao J, Wang Y

A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer

Publication : Molecular Therapy Oncolytics

Authors : Wang N, Wang J, Zhang Z, Cao H, Yan W, Chu Y, Chard Dunmall LS and Wang Y (2021)

A new oncolytic Vaccinia virus augments anti-tumor immune responses to prevent tumor recurrence and metastasis after surgery

Publication : BMJ Journals

Authors : Lu S, Zhang Z, Du P, Chard LS, Yan W, El-Khouri M, Wang Z, Zhang Z, Chu Y, Gao D, Zhang Q, Zhang L, Nagano A, Wang J, Chelala C, Lui J, Chen J, Liu P, Dong Y, Wang S, Li X, Dong J, Lemoine NR, Pei D and Wang Y. (2019)

A Virus-Infected Reprogrammed Somatic cell-derived Tumor cell (VIReST) vaccination regime can prevent initiation and progression of pancreatic cancer

Publication : AACR Journals

Authors : Lu S, Zhang Z, Du P, Chard LS, Yan W, El-Khouri M, Wang Z, Zhang Z, Chu Y, Gao D, Zhang Q, Zhang L, Nagano A, Wang J, Chelala C, Lui J, Chen J, Liu P, Dong Y, Wang S, Li X, Dong J, Lemoine NR, Pei D and Wang Y. (2019)

Immune checkpoint inhibitors in cancer therapy

Publication : The Journal of Biomedical Research

Authors : Webb ES, Liu P, Baleeiro R, Lemoine NR, Yuan M, Wang YH

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Publication : Nature Communications

Authors : Wang P, Li X, Wang J, Gao D, Li Y, Li H, Chu Y, Zhang Z, Liu H, Jiang G, Cheng Z, Wang S, Dong J, Feng B, Chard LS, Lemoine NR and Wang Y. (2017)

load more +